-
1
-
-
0025239328
-
Hepatitis B: Global importance and need for control
-
Maynard JE. Hepatitis B: global importance and need for control. Vaccine 1990, 8:S18-S20
-
(1990)
Vaccine
, vol.8
-
-
Maynard, J.E.1
-
2
-
-
0019451351
-
Hepatocellular Carcinoma and Hepatitis B: A prospective study of 22,707 men in Taiwan
-
Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular Carcinoma and Hepatitis B: a prospective study of 22,707 men in Taiwan. Lancet 1981, 2:1129-33.
-
(1981)
Lancet
, vol.2
, pp. 1129-1133
-
-
Beasley, R.P.1
Hwang, L.Y.2
Lin, C.C.3
Chien, C.S.4
-
3
-
-
0023125896
-
A serological follow up of the 1942 epidemic of post-vaccination hepatitis in the United States Army
-
Seef B, Beebe GW, Hoofnagle JH. A serological follow up of the 1942 epidemic of post-vaccination hepatitis in the United States Army. N Engl J Med 1987, 316: 965
-
(1987)
N. Engl. J. Med.
, vol.316
, pp. 965
-
-
Seef, B.1
Beebe, G.W.2
Hoofnagle, J.H.3
-
4
-
-
0020682268
-
Postnatal infectivity of hepatitis B surface antigen carrier mothers
-
Beasley RP, Hwang GY. Postnatal infectivity of hepatitis B surface antigen carrier mothers. J Infect Dis 1983, 147: 185-90
-
(1983)
J. Infect. Dis.
, vol.147
, pp. 185-190
-
-
Beasley, R.P.1
Hwang, G.Y.2
-
5
-
-
0025892665
-
Hepatitis B: Evolving epidemiology and implications for control
-
Margoli HS, Alter MJ, Hadler SC. Hepatitis B: evolving epidemiology and implications for control. Semin Liver Dis 1991, 11:84-92
-
(1991)
Semin. Liver Dis.
, vol.11
, pp. 84-92
-
-
Margoli, H.S.1
Alter, M.J.2
Hadler, S.C.3
-
6
-
-
0034078342
-
Hepatitis B: An important public health issue
-
Maddrey WC. Hepatitis B: an important public health issue. J Med Virol 2000, 61:362-366
-
(2000)
J. Med. Virol.
, vol.61
, pp. 362-366
-
-
Maddrey, W.C.1
-
7
-
-
0029893146
-
Long -term follow up of HBeAg positive patients treated with IFN-alpha for Chronic Hepatitis B
-
Niederau C, Heintges T, Lange S, Goldman G, Mohr L, Haussinger D. Long -term follow up of HBeAg positive patients treated with IFN-alpha for Chronic Hepatitis B. N Eng J Med 1996, 334: 1422-1427
-
(1996)
N. Eng. J. Med.
, vol.334
, pp. 1422-1427
-
-
Niederau, C.1
Heintges, T.2
Lange, S.3
Goldman, G.4
Mohr, L.5
Haussinger, D.6
-
8
-
-
0023243960
-
Spontaneous hepatitis e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection
-
Lok A, Lai CL, Wu P, Leung EKY, Lam TS. Spontaneous hepatitis e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection. Gastroenterology 1987, 92:18-39
-
(1987)
Gastroenterology
, vol.92
, pp. 18-39
-
-
Lok, A.1
Lai, C.L.2
Wu, P.3
Leung, E.K.Y.4
Lam, T.S.5
-
9
-
-
0027378724
-
Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B: A meta-analysis
-
Wong DKH, Cheung AM, O'Rourke, Naylor CD, Detsky AS, Heathcote J. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B: a meta-analysis. Ann Intern Med 1993, 119:312-23
-
(1993)
Ann. Intern. Med.
, vol.119
, pp. 312-323
-
-
Wong, D.K.H.1
Cheung, A.M.2
O'Rourke3
Naylor, C.D.4
Detsky, A.S.5
Heathcote, J.6
-
10
-
-
0026602420
-
A controlled trial of interferon with or without prednisone priming for chronic hepatitis B
-
Lok ASF, Wu PC, Lai CL, Lau JY, Leung EK, Wong LS, Ma OC, Lauder IJ, Ng CP, Chung HT. A controlled trial of interferon with or without prednisone priming for chronic hepatitis B. Gastroenterology 1992, 102: 2091-2097
-
(1992)
Gastroenterology
, vol.102
, pp. 2091-2097
-
-
Lok, A.S.F.1
Wu, P.C.2
Lai, C.L.3
Lau, J.Y.4
Leung, E.K.5
Wong, L.S.6
Ma, O.C.7
Lauder, I.J.8
Ng, C.P.9
Chung, H.T.10
-
11
-
-
0032499913
-
A one year trial of Lamivudine for chronic hepatitis B
-
Lai C-L, Chien R-N, Nancy WY, Chang TT, Guan R, Tai DI, Ng KY, Wu PC, Dent JC, Barber J, Stephenson SL, Gray F. A one year trial of Lamivudine for chronic hepatitis B. N Engl J Med 1998, 339:61-68
-
(1998)
N. Engl. J. Med.
, vol.339
, pp. 61-68
-
-
Lai, C.-L.1
Chien, R.-N.2
Nancy, W.Y.3
Chang, T.T.4
Guan, R.5
Tai, D.I.6
Ng, K.Y.7
Wu, P.C.8
Dent, J.C.9
Barber, J.10
Stephenson, S.L.11
Gray, F.12
-
12
-
-
0033592764
-
Lamivudine as initial treatment for chronic hepatitis B in the United States
-
Dienstag JL, Schiff ER, Wright TL, Perillo RP, Hann HW, Goodman Z, Crowther L, Condreay LD, Woessner M, Rubin M, Brown NA. Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med 1999, 341: 1256-1263
-
(1999)
N. Engl. J. Med.
, vol.341
, pp. 1256-1263
-
-
Dienstag, J.L.1
Schiff, E.R.2
Wright, T.L.3
Perillo, R.P.4
Hann, H.W.5
Goodman, Z.6
Crowther, L.7
Condreay, L.D.8
Woessner, M.9
Rubin, M.10
Brown, N.A.11
-
13
-
-
18444367980
-
Predictors of HBeAg loss after Lamivudine treatment for Chronic Hepatitis B
-
Perillo R P, Lai CL, Liaw YF, Dienstag JL, Schiff ER, Schalm SW, Heathcote EJ, Brown NA, Atkins M, Woessner M, Gardner SD. Predictors of HBeAg loss after Lamivudine treatment for Chronic Hepatitis B. Hepatology 2002, 36: 186-194.
-
(2002)
Hepatology
, vol.36
, pp. 186-194
-
-
Perillo, R.P.1
Lai, C.L.2
Liaw, Y.F.3
Dienstag, J.L.4
Schiff, E.R.5
Schalm, S.W.6
Heathcote, E.J.7
Brown, N.A.8
Atkins, M.9
Woessner, M.10
Gardner, S.D.11
-
14
-
-
0032869876
-
Pretreatment ALT level as a determinant for Hepatitis B eAg seroconversion during Lamivudine treatment in patients with Hepatitis B
-
Chien RN, Liaw Y-F, Atkins M. Pretreatment ALT level as a determinant for Hepatitis B eAg seroconversion during Lamivudine treatment in patients with Hepatitis B. Hepatology 1999, 30: 770-774.
-
(1999)
Hepatology
, vol.30
, pp. 770-774
-
-
Chien, R.N.1
Liaw, Y.-F.2
Atkins, M.3
-
15
-
-
0033802362
-
Long term treatment of Chronic Hepatitis B with Lamivudine
-
Lau DT-Y, Khokhar F, Doo E, Ghany MG, Herion D, Park Y, Kleiner D, Schmid P, Condreay L, Gauthier J, Kuhns M, Liang TJ, Hoofnagle J. Long term treatment of Chronic Hepatitis B with Lamivudine. Hepatology 2000, 32: 828-834.
-
(2000)
Hepatology
, vol.32
, pp. 828-834
-
-
Lau, D.T.-Y.1
Khokhar, F.2
Doo, E.3
Ghany, M.G.4
Herion, D.5
Park, Y.6
Kleiner, D.7
Schmid, P.8
Condreay, L.9
Gauthier, J.10
Kuhns, M.11
Liang, T.J.12
Hoofnagle, J.13
-
16
-
-
0034993211
-
Extended Lamivudine treatment in patients with Chronic Hepatitis B enhances HBeAg seroconversion rates: Results after 3 years of treatment
-
Leung NW, Lai C-L, Chang T-T, Guan R, Lee CM, Ng KY, Lim SG, Wu PC, Dent JC, Edmondson S, Condreay L, Chien RN. Extended Lamivudine treatment in patients with Chronic Hepatitis B enhances HBeAg seroconversion rates: Results after 3 years of treatment. Hepatology 2001, 33: 1527-1532.
-
(2001)
Hepatology
, vol.33
, pp. 1527-1532
-
-
Leung, N.W.1
Lai, C.-L.2
Chang, T.-T.3
Guan, R.4
Lee, C.M.5
Ng, K.Y.6
Lim, S.G.7
Wu, P.C.8
Dent, J.C.9
Edmondson, S.10
Condreay, L.11
Chien, R.N.12
-
17
-
-
0033012793
-
Efficacy of lamivudine with patients with HBeAg -ve hepatitis B virus DNA positive [precore mutant] Chronic Hepatitis B
-
Tassopoullous NC, Volpes R, Pastore G, Heathcote J, Buti M, Goldin RD, Hawley S, Barber J, Condreay L, Gray DF. Efficacy of lamivudine with patients with HBeAg -ve hepatitis B virus DNA positive [precore mutant] Chronic Hepatitis B. Hepatology 1999, 29: 889-896.
-
(1999)
Hepatology
, vol.29
, pp. 889-896
-
-
Tassopoullous, N.C.1
Volpes, R.2
Pastore, G.3
Heathcote, J.4
Buti, M.5
Goldin, R.D.6
Hawley, S.7
Barber, J.8
Condreay, L.9
Gray, D.F.10
-
18
-
-
0000232050
-
Durability of HBeAg seroconversion after Lamivudine monotherapy in phase II and III trial
-
(abstract 1)
-
Schiff E, Chancier J, Rowley K, Norkrans G, Perillo R, Tong M, Crowther L. Durability of HBeAg seroconversion after Lamivudine monotherapy in phase II and III trial. Hepatology 1998, 28:163A(abstract 1)
-
(1998)
Hepatology
, vol.28
-
-
Schiff, E.1
Chancier, J.2
Rowley, K.3
Norkrans, G.4
Perillo, R.5
Tong, M.6
Crowther, L.7
-
19
-
-
0033797827
-
HBeAg seroconversion after Lamivudine treatment is not durable in patients with chronic hepatitis B in Korea
-
Oct
-
Song BC, Suh DJ, Lee HC, Chung YH, Lee YS. HBeAg seroconversion after Lamivudine treatment is not durable in patients with chronic hepatitis B in Korea. Hepatology 2000, Oct; 32: 803-6
-
(2000)
Hepatology
, vol.32
, pp. 803-806
-
-
Song, B.C.1
Suh, D.J.2
Lee, H.C.3
Chung, Y.H.4
Lee, Y.S.5
-
20
-
-
0036844794
-
Durability of Lamivudine induced HBeAg seroconversion for chronic hepatitis B patients with acute exacerbation
-
Nov
-
Lee CM, Ong GY, Lu SN et al. Durability of Lamivudine induced HBeAg seroconversion for chronic hepatitis B patients with acute exacerbation. J Hepatol. 2002 Nov; 32(5): 669-74
-
(2002)
J. Hepatol.
, vol.32
, Issue.5
, pp. 669-674
-
-
Lee, C.M.1
Ong, G.Y.2
Lu, S.N.3
-
21
-
-
0037371305
-
Significance of hepatitis B genotype in acute exacerbation, HBeAg seroconversion, and cirrhosis related complications and HCC
-
Man FY, Erwin S, He-Jun Y, Decraemer H, Lai CL. Significance of hepatitis B genotype in acute exacerbation, HBeAg seroconversion, and cirrhosis related complications and HCC. Hepatology. 2003, 37:562-567.
-
(2003)
Hepatology
, vol.37
, pp. 562-567
-
-
Man, F.Y.1
Erwin, S.2
He-Jun, Y.3
Decraemer, H.4
Lai, C.L.5
-
22
-
-
84984535720
-
Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B
-
Kao JH, Chen PJ, Lai MY, Chen DS. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology 2000, 118:554-559.
-
(2000)
Gastroenterology
, vol.118
, pp. 554-559
-
-
Kao, J.H.1
Chen, P.J.2
Lai, M.Y.3
Chen, D.S.4
-
23
-
-
0034235528
-
Effects of extended Lam treatment in Asian patients with Chronic Hepatitis B
-
Liaw YF, Leung NW, Chang T-T, Guan R, Tai DI, Ng KY, Chien RN, Dent J, Roman L, Edmondson S, Condreay L, Chien RN. Effects of extended Lam treatment in Asian patients with Chronic Hepatitis B. Gastroenterology 2000, 119: 172-180.
-
(2000)
Gastroenterology
, vol.119
, pp. 172-180
-
-
Liaw, Y.F.1
Leung, N.W.2
Chang, T.-T.3
Guan, R.4
Tai, D.I.5
Ng, K.Y.6
Chien, R.N.7
Dent, J.8
Roman, L.9
Edmondson, S.10
Condreay, L.11
Chien, R.N.12
-
24
-
-
0001760398
-
Pathogenesis and significance of acute exacerbation and remission in patients with Chronic Hepatitis B virus infection
-
Liaw YF, Tsai SL. Pathogenesis and significance of acute exacerbation and remission in patients with Chronic Hepatitis B virus infection. Viral Hep Rev 1997, 3: 143-154.
-
(1997)
Viral Hep. Rev.
, vol.3
, pp. 143-154
-
-
Liaw, Y.F.1
Tsai, S.L.2
-
25
-
-
0028916425
-
Hepatitis B virus immunopathogenesis
-
Chisari FV, Ferrari. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995; 13, 29-60
-
(1995)
Annu. Rev. Immunol.
, vol.13
, pp. 29-60
-
-
Chisari, F.V.1
Ferrari2
-
26
-
-
0023260440
-
Reactivation of chronic hepatitis B infection
-
Davis GL, Hoofnagle JH. Reactivation of chronic hepatitis B infection. Gastroenterology 1987, 92:2028-2031
-
(1987)
Gastroenterology
, vol.92
, pp. 2028-2031
-
-
Davis, G.L.1
Hoofnagle, J.H.2
-
27
-
-
0032169470
-
Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B
-
Boni C, Bertoletti A, Penn A, Cavalli A, Pilli M, Urbani S, Scognamiglio P, Boehme R, Panebianco R, Fiaccadori F, Ferrari C. Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. J Clin Invest 1998, 102:968-975
-
(1998)
J. Clin. Invest.
, vol.102
, pp. 968-975
-
-
Boni, C.1
Bertoletti, A.2
Penn, A.3
Cavalli, A.4
Pilli, M.5
Urbani, S.6
Scognamiglio, P.7
Boehme, R.8
Panebianco, R.9
Fiaccadori, F.10
Ferrari, C.11
-
28
-
-
0021365713
-
Spontaneous reactivation of chronic hepatitis B virus infection
-
Davis GL, Hoofnagle JH, Waggoner JG. Spontaneous reactivation of chronic hepatitis B virus infection. Gastroenterology 1984, 86:230-235
-
(1984)
Gastroenterology
, vol.86
, pp. 230-235
-
-
Davis, G.L.1
Hoofnagle, J.H.2
Waggoner, J.G.3
-
29
-
-
0026058540
-
Inhibition of the replication of hepatitis B virus in vitro by 2′ 3′-dideoxy-3′-thiacytidine and related analogues
-
Doong SL, Tsai CH, Schinazi RF, Liotta DC, Cheng YC. Inhibition of the replication of hepatitis B virus in vitro by 2′ 3′-dideoxy-3′-thiacytidine and related analogues. Proc Natl Acad Sci USA 1991, 88:8495-8499
-
(1991)
Proc. Natl. Acad. Sci. USA
, vol.88
, pp. 8495-8499
-
-
Doong, S.L.1
Tsai, C.H.2
Schinazi, R.F.3
Liotta, D.C.4
Cheng, Y.C.5
-
30
-
-
0030864783
-
Dynamics of hepatitis B virus infection in vivo
-
Zeuzem S, deMan RA, Honkoop P, Roth W, Schalm S, Schmidt J. Dynamics of hepatitis B virus infection in vivo. J Hepatol 1997, 27:431-436
-
(1997)
J. Hepatol.
, vol.27
, pp. 431-436
-
-
Zeuzem, S.1
de Man, R.A.2
Honkoop, P.3
Roth, W.4
Schalm, S.5
Schmidt, J.6
-
31
-
-
0032783679
-
Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during Lamivudine treatment
-
Liaw YF, Chien R-N, Yeh C-T, Tsai-S-L. Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during Lamivudine treatment. Hepatology 1999, 30: 567-572.
-
(1999)
Hepatology
, vol.30
, pp. 567-572
-
-
Liaw, Y.F.1
Chien, R.-N.2
Yeh, C.-T.3
Tsai, S.-L.4
-
32
-
-
0029815110
-
Selection of mutations in the hepatitis B virus polymerase during treatment of transplant recepients with Lamivudine
-
Ling R, Mutimer D, Ahmed M, Boxall EH, Elias E, Dushieko GM, Harrison TJ. Selection of mutations in the hepatitis B virus polymerase during treatment of transplant recepients with Lamivudine. Hepatology 1996, 24: 711-713.
-
(1996)
Hepatology
, vol.24
, pp. 711-713
-
-
Ling, R.1
Mutimer, D.2
Ahmed, M.3
Boxall, E.H.4
Elias, E.5
Dushieko, G.M.6
Harrison, T.J.7
-
33
-
-
0001131529
-
Two year Lamivudine treatment in Chronic Hepatitis B infection- results of a placebo controlled multicentre study in Asia
-
Liaw Y-F, Lai CL, Leung NW, Chang TT, Guan R, Tau DI, Ng KY, Chien RN, Dent J, Roman L, Edmondson S, Condreay L, Chien RN. Two year Lamivudine treatment in Chronic Hepatitis B infection- results of a placebo controlled multicentre study in Asia. Gastroenterology 1998, 114: A 1289.
-
(1998)
Gastroenterology
, vol.114
-
-
Liaw, Y.-F.1
Lai, C.L.2
Leung, N.W.3
Chang, T.T.4
Guan, R.5
Tau, D.I.6
Ng, K.Y.7
Chien, R.N.8
Dent, J.9
Roman, L.10
Edmondson, S.11
Condreay, L.12
Chien, R.N.13
-
34
-
-
0000859208
-
Enhanced HBeAg seroconversion rates in Chinese patients on Lamivudine
-
Chang T-T, Lai CL, Liaw Y-F, Leung NWY, Guan R, Lim SG, Lee CM. Enhanced HBeAg seroconversion rates in Chinese patients on Lamivudine. Hepatology 1999, 30:420A.
-
(1999)
Hepatology
, vol.30
-
-
Chang, T.-T.1
Lai, C.L.2
Liaw, Y.-F.3
Leung, N.W.Y.4
Guan, R.5
Lim, S.G.6
Lee, C.M.7
-
35
-
-
0036836580
-
Prevalence and treatment profile of Mutations associated with Lamivudine treatment in Indian patients with Chronic Hepatitis B in the surface and Polymerase genes of HBV
-
Wakil JM, Kazim SN, Khan CA, Raisuddin S, Parvez M, Guptan R, Thakur V, Hasnain S, Sarin SK. Prevalence and treatment profile of Mutations associated with Lamivudine treatment in Indian patients with Chronic Hepatitis B in the surface and Polymerase genes of HBV. J. Med Virol 2002, 68: 311-318.
-
(2002)
J. Med. Virol.
, vol.68
, pp. 311-318
-
-
Wakil, J.M.1
Kazim, S.N.2
Khan, C.A.3
Raisuddin, S.4
Parvez, M.5
Guptan, R.6
Thakur, V.7
Hasnain, S.8
Sarin, S.K.9
-
36
-
-
0033957572
-
A new genotype of hepatitis B virus: Complete genomes and phylogenetic relatedness
-
Stuyver L, De Gendt S, Van Geyt C, Zoulim F, Fried M, Schinazi RF, Rossau R. A new genotype of hepatitis B virus: complete genomes and phylogenetic relatedness. J Gen Virol 2000, 81: 67-74
-
(2000)
J. Gen. Virol.
, vol.81
, pp. 67-74
-
-
Stuyver, L.1
De Gendt, S.2
Van Geyt, C.3
Zoulim, F.4
Fried, M.5
Schinazi, R.F.6
Rossau, R.7
-
37
-
-
0032959493
-
Core Promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers
-
Lindh M, Hannoun C, Dhillon AP, Norkrans G, Horal P. Core Promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers. J Infect Dis 1999, 179: 775-82
-
(1999)
J. Infect. Dis.
, vol.179
, pp. 775-782
-
-
Lindh, M.1
Hannoun, C.2
Dhillon, A.P.3
Norkrans, G.4
Horal, P.5
-
38
-
-
84983726628
-
Hepatitis B genotypes and the response to interferon therapy
-
Kao JH, Wu NH, Chen PJ, Lai MY, Chen DS. Hepatitis B genotypes and the response to interferon therapy. J Hepatol 2000, 33:998-1002
-
(2000)
J. Hepatol.
, vol.33
, pp. 998-1002
-
-
Kao, J.H.1
Wu, N.H.2
Chen, P.J.3
Lai, M.Y.4
Chen, D.S.5
-
39
-
-
0036224207
-
Profile, spectrum and significance of HBV genotypes in chronic liver disease patients in the Indian subcontinent
-
Thakur V, Guptan RC, Kazim SN, Malhotra V, Sarin SK. Profile, spectrum and significance of HBV genotypes in chronic liver disease patients in the Indian subcontinent. J Gastroenterol Hepatol. 2002, 17(2): 165-170
-
(2002)
J. Gastroenterol. Hepatol.
, vol.17
, Issue.2
, pp. 165-170
-
-
Thakur, V.1
Guptan, R.C.2
Kazim, S.N.3
Malhotra, V.4
Sarin, S.K.5
-
40
-
-
0033998982
-
Mutations of core promoter and response to interferon treatment in chronic replicative hepatitis B
-
Erhardt A, Reineke U, Blondin D. Mutations of core promoter and response to interferon treatment in chronic replicative hepatitis B. Hepatology 2000, 31:716-725
-
(2000)
Hepatology
, vol.31
, pp. 716-725
-
-
Erhardt, A.1
Reineke, U.2
Blondin, D.3
-
41
-
-
0030004556
-
Analysis of hepatitis B virus genotypes and pre-core region variability during IFN treatment of HBe antigen negative CHB
-
Zhang X, Zoulim F, Habersetzer F. Analysis of hepatitis B virus genotypes and pre-core region variability during IFN treatment of HBe antigen negative CHB. J Med Virol 1996, 48: 8-16
-
(1996)
J. Med. Virol.
, vol.48
, pp. 8-16
-
-
Zhang, X.1
Zoulim, F.2
Habersetzer, F.3
-
42
-
-
0036171680
-
Hepatitis B viral genotypes and lamivudine resistance
-
Kao JH, Liu CJ, Chen DS. Hepatitis B viral genotypes and lamivudine resistance. J Hepatol 2002, 36:303-4
-
(2002)
J. Hepatol.
, vol.36
, pp. 303-304
-
-
Kao, J.H.1
Liu, C.J.2
Chen, D.S.3
|